Kiora Pharmaceuticals
KPRX

Kiora Pharmaceuticals (KPRX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$10.00Sep 2, 2025
HC Wainwright & Co.MaintainedBuy$10.00Mar 28, 2025
HC Wainwright & Co.MaintainedBuy$10.00Nov 12, 2024
HC Wainwright & Co.MaintainedBuy$10.00Aug 22, 2024
HC Wainwright & Co.MaintainedBuy$10.00 from $2.00Jul 23, 2024
HC Wainwright & Co.MaintainedBuy$2.00May 20, 2024
HC Wainwright & Co.MaintainedBuy$2.00Mar 27, 2024
HC Wainwright & Co.MaintainedBuy$2.00 from $3.50Feb 9, 2024
HC Wainwright & Co.MaintainedBuy$3.50Nov 13, 2023
HC Wainwright & Co.MaintainedBuy$3.50 from $2.00Nov 6, 2023
HC Wainwright & Co.MaintainedBuy$2.00Aug 24, 2023
HC Wainwright & Co.MaintainedBuy$2.00 from $7.00Aug 14, 2023
Maxim GroupMaintainedBuy$2.00 from $12.00Aug 9, 2023
HC Wainwright & Co.MaintainedBuy$7.00 from $6.00May 12, 2023

Frequently asked questions

  • What is the latest analyst rating on KPRX?

    On Sep 2, 2025, HC Wainwright & Co. maintained Kiora Pharmaceuticals at Buy with a price target of $10.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.